Enzymatic repair of oxidative damage to human apolipoprotein A-I.
Oxidative damage to apolipoprotein A-I that occurs in vivo commonly involves methionine oxidation, and is accompanied by alterations in structure, lipid association, and cholesterol efflux function. We have used the enzyme peptide methionine sulfoxide reductase (PMSR) to reverse this damage, and shown by a variety of criteria that enzyme treatment restores the primary, secondary, and tertiary structure and lipid association characteristic of the native unoxidized protein. Lipid-associated as well as lipid-free apolipoprotein A-I reacts with PMSR, suggesting that enzymatic reduction of oxidized apolipoprotein A-I in high density lipoproteins can result in restoration of biological activity and the ability to promote cholesterol efflux from cells.
Sigalov
A B
AB
Biomedical Department, AMW Co. Ltd., Moscow, Russia. alexsig@cityline.ru
Stern
L J
LJ
D000818:Animals; D016632:Apolipoprotein A-I / Q000097:blood* / Q000737:chemistry*; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D002918:Chymotrypsin; D002942:Circular Dichroism; D003488:Cyanogen Bromide; D006801:Humans; D051150:Methionine Sulfoxide Reductases; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism*; D010446:Peptide Fragments / Q000737:chemistry; D011487:Protein Conformation; D011489:Protein Denaturation; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D013816:Thermodynamics
D016632:Apolipoprotein A-I; D010446:Peptide Fragments; D010088:Oxidoreductases; D051150:Methionine Sulfoxide Reductases; C027219:methionine sulfoxide reductase; D002918:Chymotrypsin; D003488:Cyanogen Bromide